Is the current approach to reviewing new drugs condemning the victims of rare diseases to death? A call for a national orphan drug review policy.
Clarke
Joe T R
JT
Department of Pediatrics, the Hospital for Sick Children and University of Toronto, Toronto, Ont. jtrc@sickkids.ca
D002170:Canada; D016527:Drug Costs / Q000706:statistics & numerical data; D004345:Drug Industry; D006291:Health Policy; D006801:Humans; D009965:Orphan Drug Production / Q000331:legislation & jurisprudence*; D011050:Policy Making; D011379:Prognosis; D035583:Rare Diseases / Q000188:drug therapy*